Metagenomi Therapeutics, Inc. (MGX)

Nasdaq · Biological Products, (No Diagnostic Substances)

What they're doing

Between June 7 and September 5, 2026, Metagenomi Therapeutics, Inc. recorded one public event. On June 10, 2026, the company filed an 8-K disclosure reporting a change in its director or officer composition, though the specific details of the change—such as whether it was a departure, appointment, or role modification—were not provided in the available data. No government contracts were recorded during the preceding 24 months, and no lobbying activity was reported for the most recent quarter. The summary reflects limited publicly available information for this period, with the single filing representing the only documented corporate activity within the specified window.

Generated 2026-09-05 from public records.

Signals, last 12 months

  1. Material 8-K filing
    Filed 8-K disclosing director or officer change
  2. Material 8-K filing
    Filed 8-K disclosing material agreement

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2026-09-09Reid LaurencedirectorP19,8831.17$23,263
2026-09-09Reid LaurencedirectorP1171.18$138
2026-09-08Wein MatthewofficerS3581.16$415
2026-09-08Irish JiandirectorS2,1401.16$2,479
2026-09-08Wapnick PamelaofficerS1,9111.16$2,214
2026-06-05Irish JiandirectorS3,7371.3$4,858
2026-06-05Wapnick PamelaofficerS2,8841.3$3,749
2026-06-05Wein MatthewofficerS5581.3$725
2026-04-01Irish JiandirectorA46,0000$0
2026-04-01Wein MatthewofficerA11,0000$0
2026-04-01Wapnick PamelaofficerA24,0000$0
2026-03-05Wapnick PamelaofficerS1,5811.6$2,530
2026-03-05Wein MatthewofficerS4821.6$771
2026-03-05Irish JiandirectorS1,6071.6$2,571
2025-12-05Irish JiandirectorG228,4620$0
2025-12-05Thomas Brian C.directorS3,8301.77$6,779
2025-12-05Wein MatthewofficerS1991.77$352
2025-12-05Wapnick PamelaofficerS1,5761.77$2,790
2025-12-05Irish JiandirectorS1,6021.77$2,836
2025-12-01Wapnick PamelaofficerA120,0001.6$192,000
2025-12-01Irish JiandirectorA37,5001.6$60,000
2025-12-01Irish JiandirectorA211,0001.6$337,600
2025-12-01Wein MatthewofficerA96,0001.6$153,600
2025-09-05Thomas Brian C.directorS2,7011.81$4,889
2025-09-05Wapnick PamelaofficerS1,5761.81$2,853
2025-09-05Irish JiandirectorS1,6021.81$2,900
2025-09-05Wein MatthewofficerS1991.81$360
2025-06-06Wein MatthewofficerS1991.75$348
2025-06-06Noonberg Sarah B.officerS5,2391.75$9,168
2025-06-06Wapnick PamelaofficerS1,5761.75$2,758
2025-06-06Thomas Brian C.directorS10,7851.75$18,874
2025-06-06Irish JiandirectorS6,3901.75$11,183
2025-04-01Wapnick PamelaofficerA14,0000$0
2025-04-01Thomas Brian C.directorA32,0000$0
2025-04-01Irish JiandirectorA23,0000$0
2025-04-01Wein MatthewofficerA3,7750$0
2025-04-01Wein MatthewofficerA3,6500$0
2025-04-01Noonberg Sarah B.officerA14,0000$0
2025-03-05Wein MatthewofficerS9301.87$1,739
2025-03-05Wapnick PamelaofficerS1,8081.87$3,381
2024-12-05Wapnick PamelaofficerS1,5591.86$2,900
2024-09-05Wapnick PamelaofficerS6,2652.88$18,043

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings

  • 2026-09-22 8-K
  • 2026-09-11 4
  • 2026-09-10 4
  • 2026-09-10 4
  • 2026-09-10 4
  • 2026-09-10 SCHEDULE 13G
  • 2026-08-10 10-Q
  • 2026-08-10 8-K
  • 2026-06-11 4
  • 2026-06-11 4
  • 2026-06-11 4
  • 2026-06-11 4
  • 2026-06-10 4
  • 2026-06-10 4
  • 2026-06-10 4
  • 2026-06-10 8-K
  • 2026-05-11 10-Q
  • 2026-05-11 8-K
  • 2026-04-27 ARS
  • 2026-04-27 DEFA14A
Metagenomi Therapeutics, Inc. (MGX): insider trades, federal contracts, lobbying | IP Files